The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

PHOENIX (AZFamily) — A ketamine-derived nasal spray is now available for the millions of Americans living with severe depression. The hallucinogenic drug is an option when traditional treatment isn’t ...

We recently published a list of 12 Safe Stocks to Buy for the Long Term in 2025. In this article, we are going to take a look ...

Johnson & Johnson (NYSE:JNJ), a global healthcare giant, finds itself at a critical juncture as it navigates a complex landscape of opportunities and challenges. The company's recent performance and ...

In its motion to dismiss, J&J asserted that the plaintiff did “not allege a concrete harm or injury-in-fact” — a claim with ...

In part 2 of our interview with Katie Abouzahr, MD, Johnson & Johnson Innovative Medicine, we discuss the challenge inherent ...

After 30 years as an attorney and more than 11 on the bench, District Judge Mark Johnson retired earlier this month in what ...

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...

The coordinators hired by Chicago Bears coach Ben Johnson enter their new jobs with vastly different amounts of coaching ...

An estimated 21 million American adults suffer from clinical depression. © 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes ...

On Tuesday, the US Food and Drug Administration (FDA) approved Johnson & Johnson's hallucinogenic drug esketamine (brand name ...

A man accused of killing a 19-year-old man while attempting to rob him during a drug deal in 2023 began his trial Tuesday. Jayveon Johnson, 23, is accused in the fatal shooting of David Rezentes.